HLPVSPACB• 6 Months (Normalized)
HLP vs PACB (Hongli Group Inc. vs Pacific Biosciences of California Inc.)
Showing Closing Date Range from Apr 9 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
HLP Performance $2.47
+179.1%
Hongli Group Inc.
Normalized Baseline0.00%
PACB Performance $2.87
+112.59%
Pacific Biosciences of California Inc.
Normalized Baseline0.00%
Alpha Spread Margin HLP LEADS
+66.51 pts
HLP outperforming by 66.51 percentage points
HLPPACB
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
HLP PACB
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | HLP Price | HLP Gain (%) | PACB Price | PACB Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $2.47 | +179.10% | $2.87 | +112.59% | +66.51% |
| Oct 02, 2026 | $2.55 | +188.14% | $2.54 | +88.15% | +99.99% |
| Oct 01, 2026 | $- | $2.51 | +85.93% | - | |
| Sep 30, 2026 | $- | $2.37 | +75.56% | - | |
| Sep 29, 2026 | $- | $1.83 | +35.56% | - | |
| Sep 28, 2026 | $2.39 | +170.06% | $1.71 | +26.67% | +143.39% |
| Sep 25, 2026 | $2.21 | +149.72% | $- | - | |
| Sep 24, 2026 | $2.20 | +148.59% | $1.46 | +7.78% | +140.81% |
| Sep 23, 2026 | $2.04 | +129.94% | $1.41 | +4.44% | +125.50% |
| Sep 22, 2026 | $2.00 | +125.99% | $- | - | |
| Sep 21, 2026 | $2.03 | +129.38% | $1.36 | +0.74% | +128.64% |
| Sep 18, 2026 | $2.02 | +128.25% | $1.37 | +1.48% | +126.77% |
| Sep 17, 2026 | $2.02 | +128.25% | $1.38 | +2.22% | +126.03% |
| Sep 16, 2026 | $2.07 | +133.90% | $1.34 | -0.74% | +134.64% |
| Sep 15, 2026 | $1.82 | +105.65% | $1.34 | -0.74% | +106.39% |
Page 1 of 9